BENF — Beneficient Income Statement
0.000.00%
- $5.05m
- $344.20m
- -$7.94m
- 11
- 85
- 52
- 47
Annual income statement for Beneficient, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 15 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 140 | -11.3 | -105 | -98.7 | -7.94 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 188 | 194 | 148 | 2,559 | 16.2 |
| Operating Profit | -47.4 | -205 | -253 | -2,657 | -24.2 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -47.4 | -205 | -253 | -2,657 | -0.723 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -50.9 | -206 | -252 | -2,658 | -0.803 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -58 | -139 | -131 | -2,096 | 51.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -58 | -139 | -131 | -2,096 | 51.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -23.3 | -47.1 | -52.6 | -164 | 0.043 |
| Dividends per Share |